## Summary
[WDR86 AS1](/details-gene/100131176) is a long non-coding RNA (lncRNA) located on human chromosome 7q36.1. As an antisense transcript to the protein-coding gene WDR86, its primary function is likely related to the regulation of its sense-strand counterpart. **Overall**, expression data reveals a highly specific and significant enrichment of [WDR86 AS1](/details-gene/100131176) in [ciliated epithelial cells](/details-cell/CL0000067), particularly within the respiratory system, such as [lung ciliated cells](/details-cell/CL1000271). This distinct expression pattern strongly suggests a specialized role in the development, maintenance, or function of cilia.
## Cellular Roles and Expression Landscape
The expression profile of [WDR86 AS1](/details-gene/100131176) is dominated by a strong and specific signature in ciliated cell lineages. It is most significant in [ciliated epithelial cell](/details-cell/CL0000067) (CSI: 21.29) and related subtypes like [lung ciliated cell](/details-cell/CL1000271) (CSI: 11.85) and [ciliated columnar cell of tracheobronchial tree](/details-cell/CL0002145) (CSI: 5.21). The high CSI values in these cell types indicate that [WDR86 AS1](/details-gene/100131176) is a defining molecular feature of this cellular machinery.
Interestingly, the gene also shows moderate significance in specific immune cell populations, including [group 3 innate lymphoid cells](/details-cell/CL0001071) (CSI: 7.38) and [effector memory CD4-positive, alpha-beta T cells](/details-cell/CL0000905) (CSI: 3.24). The presence of this lncRNA in both epithelial barrier cells and resident immune cells at mucosal surfaces may suggest a coordinated role in host defense or tissue homeostasis in environments like the respiratory tract.
## Pathways and Molecular Function
Detailed functional annotations for [WDR86 AS1](/details-gene/100131176) are not yet well-established. However, its designation as an antisense RNA to the *WDR86* gene provides a strong-prior hypothesis for its mechanism of action. Antisense lncRNAs typically regulate the expression of their corresponding sense gene through mechanisms such as transcriptional interference, chromatin modification, or by altering mRNA stability and translation. Therefore, it is highly probable that [WDR86 AS1](/details-gene/100131176) functions to fine-tune the expression of WDR86, a WD repeat-containing protein, within the specialized cellular contexts where it is expressed, primarily ciliated cells.
## Research Directions
The specific expression pattern of [WDR86 AS1](/details-gene/100131176) in ciliated cells, coupled with its antisense nature, points toward several key research avenues.
**Proposed Hypotheses:**
1. [WDR86 AS1](/details-gene/100131176) acts as a negative regulator of WDR86 protein expression in [ciliated epithelial cells](/details-cell/CL0000067), and this regulatory axis is essential for proper ciliogenesis or the maintenance of ciliary beat frequency.
2. The expression of [WDR86 AS1](/details-gene/100131176) in [group 3 innate lymphoid cells](/details-cell/CL0001071) suggests it may be involved in modulating ILC3 responses to epithelial-derived signals, potentially influencing mucosal immunity in the lung or gut.
**Key Experimental Approach:**
To test the primary hypothesis of regulatory function, a loss-of-function study could be performed. Human bronchial epithelial cells could be cultured at an air-liquid interface to induce differentiation into a ciliated epithelium. These cultures would then be treated with antisense oligonucleotides (ASOs) designed to specifically degrade [WDR86 AS1](/details-gene/100131176) transcripts. The functional consequences would be assessed by quantifying changes in WDR86 mRNA and protein levels via RT-qPCR and western blot, and by evaluating ciliary structure and function through high-resolution microscopy and ciliary beat frequency analysis.
**Therapeutic Potential:**
Given its high specificity for ciliated cells, [WDR86 AS1](/details-gene/100131176) could be a promising therapeutic target for diseases involving ciliary dysfunction (ciliopathies), such as primary ciliary dyskinesia or chronic obstructive pulmonary disease (COPD). Therapeutic strategies would likely employ ASO-based technologies. If [WDR86 AS1](/details-gene/100131176) is found to repress WDR86, then ASO-mediated inhibition of the lncRNA could serve as a novel approach to increase WDR86 protein levels, potentially restoring ciliary function in diseases where WDR86 activity is compromised.
Disclaimer: This in-silico analysis is generated by an AI language model and may contain inaccuracies or hallucinations. However, it is cross-referenced with curated gene expression data from major biological sources. Please verify the information before use.